{"article": ["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients ."], "abstract": ["genetics institute shares rise on prospects for unk drug"], "candidates": [[["genetics institute inc. shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["genetic institute shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.24853801169590647], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "company shares rose as much as #.# percent."], 0.14517374517374518], [["the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.13051538746755653], [["genetic institute inc shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "the drug is called a new kinase inhibitor."], 0.12058212058212057], [["genetic institute plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.23952539859102706], [["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug."], 0.20158730158730162], [["genesys plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "shares rose as much as #.# percent."], 0.1492374727668845], [["shares of genetics institute inc. rise by up to 8%.", "company plans to seek early government approval of drug it claims reduces need for unk transfusions by chemotherapy patients."], 0.24756335282651074], [["genetics institute inc. shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["genetics institute inc. shares rise to $8.50.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.28362573099415206], [["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug."], 0.20158730158730162]], "article_untok": ["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients ."], "abstract_untok": ["genetics institute shares rise on prospects for unk drug"], "candidates_untok": [[["genetics institute inc. shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["genetic institute shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.24853801169590647], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "company shares rose as much as #.# percent."], 0.14517374517374518], [["the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.13051538746755653], [["genetic institute inc shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["the company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "the drug is called a new kinase inhibitor."], 0.12058212058212057], [["genetic institute plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.23952539859102706], [["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug."], 0.20158730158730162], [["genesys plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients.", "shares rose as much as #.# percent."], 0.1492374727668845], [["shares of genetics institute inc. rise by up to 8%.", "company plans to seek early government approval of drug it claims reduces need for unk transfusions by chemotherapy patients."], 0.24756335282651074], [["genetics institute inc. shares rose as much as #.# percent.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.22407022407022406], [["company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.1349206349206349], [["genetics institute inc. shares rise to $8.50.", "company plans to seek early government approval of a drug it claims reduces the need for unk transfusions by chemotherapy patients."], 0.28362573099415206], [["genetics institute inc. shares rose as much as #.# percent as the company plans to seek early government approval of a drug."], 0.20158730158730162]]}